GlaxoSmithKline PLC.
701 announcements.
701 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 12-08-2022 | GSK | GSK PLC | Statement: Zantac (ranitidine) litigation |
| 11:51 | 11-08-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 16:57 | 10-08-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 13:43 | 01-08-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 14:00 | 29-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 10:00 | 29-07-2022 | GSK | GSK PLC | GSK Board change |
| 13:01 | 28-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 07:00 | 27-07-2022 | GSK | GSK PLC | 2nd Quarter Results |
| 16:45 | 22-07-2022 | GSK | GSK PLC | Holding(s) in Company |
| 16:17 | 22-07-2022 | GSK | GSK PLC | Board and Committee Changes |
| 07:00 | 19-07-2022 | GSK | GSK PLC | Completion of GSK Share Consolidation |
| 07:00 | 18-07-2022 | GSK | GSK PLC | Haleon demerger completion and share consolidation |
| 09:48 | 12-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 17:30 | 08-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 15:53 | 08-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 15:33 | 08-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 15:10 | 08-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 16:30 | 06-07-2022 | GSK | GSK PLC | Result of General Meeting |
| 10:11 | 06-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 12:43 | 05-07-2022 | GSK | GSK PLC | GSK disclose discontinued operations from Q2 2022 |
| 09:45 | 05-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 09:30 | 05-07-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 15:27 | 01-07-2022 | GSK | GSK PLC | Total Voting Rights |
| 14:45 | 01-07-2022 | GSK | GSK PLC | GSK completes acquisition of Sierra Oncology |
| 07:00 | 28-06-2022 | GSK | GSK PLC | GSK files Shingrix 18+ at risk indication in Japan |
| 16:08 | 27-06-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 15:44 | 24-06-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 10:58 | 16-06-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 07:00 | 10-06-2022 | GSK | GSK PLC | Positive phase III data for GSK's RSV OA vaccine |
| 16:28 | 09-06-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 17:17 | 07-06-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 12:00 | 07-06-2022 | GSK | Hardman & Co Research | Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis |
| 07:00 | 06-06-2022 | GSK | GSK PLC | US FDA approval of Priorix |
| 16:55 | 01-06-2022 | GSK | GSK PLC | Total Voting Rights |
| 13:00 | 01-06-2022 | GSK | GSK PLC | Demerger update: Publication of Documents |
| 07:00 | 01-06-2022 | GSK | GSK PLC | Demerger update: Submission of Documents to FCA |
| 07:00 | 31-05-2022 | GSK | GSK PLC | GSK to acquire Affinivax, Inc. |
| 10:00 | 30-05-2022 | GSK | GSK PLC | Further appointments to Designate Haleon Board |
| 07:00 | 27-05-2022 | GSK | GSK PLC | GSK Cervarix two-dose schedule approved by NMPA |
| 15:41 | 25-05-2022 | GSK | GSK Plc | Director/PDMR Shareholding |
| 15:21 | 23-05-2022 | GSK | GSK PLC | Director/PDMR Shareholding |
| 10:02 | 19-05-2022 | GSK | GSK PLC | Iain Mackay - External Appointment |
| 14:00 | 16-05-2022 | GSK | GlaxoSmithKline PLC | Change of name to GSK plc |
| 17:13 | 13-05-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 08:58 | 12-05-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:17 | 11-05-2022 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 14:53 | 09-05-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:49 | 04-05-2022 | GSK | GlaxoSmithKline PLC | Result of AGM |
| 10:00 | 04-05-2022 | GSK | GlaxoSmithKline PLC | Directorate Change |
| 16:52 | 03-05-2022 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 27-04-2022 | GSK | GlaxoSmithKline PLC | 1st Quarter Results |
| 09:32 | 26-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 19-04-2022 | GSK | GlaxoSmithKline PLC | Daprodustat application accepted for review by FDA |
| 14:23 | 14-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:15 | 14-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:29 | 14-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:11 | 13-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:32 | 13-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 13-04-2022 | GSK | GlaxoSmithKline PLC | GSK agrees to acquire Sierra Oncology for $1.9bn |
| 17:10 | 12-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:23 | 12-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:00 | 12-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:48 | 12-04-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:03 | 01-04-2022 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 11:20 | 01-04-2022 | GSK | GlaxoSmithKline PLC | GSK - segment and product sales reporting changes |
| 13:00 | 28-03-2022 | GSK | GlaxoSmithKline PLC | Publication of 2022 AGM Notice |
| 15:22 | 24-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 24-03-2022 | GSK | GlaxoSmithKline PLC | FDA update: Cabenuva oral lead-in now optional |
| 17:03 | 23-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 23-03-2022 | GSK | GlaxoSmithKline PLC | Issuance of Notes |
| 14:40 | 16-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:45 | 15-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:00 | 15-03-2022 | GSK | GlaxoSmithKline PLC | Appointments to Designate Haleon Board |
| 14:55 | 11-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:44 | 09-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:03 | 04-03-2022 | GSK | GlaxoSmithKline PLC | GSK publishes Annual Report 2021 |
| 14:30 | 01-03-2022 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:18 | 01-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:55 | 01-03-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 01-03-2022 | GSK | GlaxoSmithKline PLC | Daprodustat application accepted for review by EMA |
| 11:00 | 28-02-2022 | GSK | GlaxoSmithKline PLC | GSK introduces Haleon to investors |
| 07:00 | 28-02-2022 | GSK | GlaxoSmithKline PLC | GSK RSV maternal vaccine candidate further update |
| 16:22 | 24-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:12 | 24-02-2022 | GSK | GlaxoSmithKline PLC | Canada Approval For Medicago GSK Covid-19 Vaccine |
| 14:50 | 23-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 22-02-2022 | GSK | GlaxoSmithKline PLC | GSK Consumer Healthcare to be called Haleon |
| 09:22 | 22-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:30 | 18-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 18-02-2022 | GSK | GlaxoSmithKline PLC | GSK gives update on RSV maternal vaccine candidate |
| 16:00 | 17-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:40 | 17-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:20 | 17-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:50 | 17-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:19 | 17-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:50 | 14-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:26 | 14-02-2022 | GSK | GlaxoSmithKline PLC | Transfer of Treasury Shares |
| 14:06 | 11-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:33 | 11-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 10-02-2022 | GSK | GlaxoSmithKline PLC | Benlysta approved in China for Lupus Nephritis |
| 11:07 | 09-02-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 09-02-2022 | GSK | GlaxoSmithKline PLC | Final Results |
| 10:30 | 07-02-2022 | GSK | GlaxoSmithKline PLC | Publication of full year 2021 results: Replacement |
| 10:00 | 07-02-2022 | GSK | GlaxoSmithKline PLC | Publication of full year 2021 results |
| 07:00 | 02-02-2022 | GSK | GlaxoSmithKline PLC | GSK announces settlement between ViiV and Gilead |
| 13:44 | 01-02-2022 | GSK | GlaxoSmithKline PLC | FDA approves ViiV Healthcare's sNDA for Cabenuva |
| 11:44 | 01-02-2022 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 15:59 | 20-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:33 | 19-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:14 | 19-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:10 | 19-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 19-01-2022 | GSK | GlaxoSmithKline PLC | Tony Wood appointed CSO Designate, GSK |
| 17:04 | 17-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:07 | 17-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 17-01-2022 | GSK | GlaxoSmithKline PLC | Update - GSK Consumer Healthcare |
| 15:22 | 14-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:12 | 13-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:28 | 11-01-2022 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:08 | 11-01-2022 | GSK | GlaxoSmithKline PLC | US Govt buys additional 600,000 sotrovimab doses |
| 12:28 | 04-01-2022 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:11 | 23-12-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:57 | 22-12-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 21-12-2021 | GSK | GlaxoSmithKline PLC | ViiV Healthcare announces FDA approval of Apretude |
| 07:00 | 20-12-2021 | GSK | GlaxoSmithKline PLC | Consumer Healthcare Chair Designate appointed |
| 12:48 | 17-12-2021 | GSK | GlaxoSmithKline PLC | Xevudy approved in Europe to treat COVID-19 |
| 07:00 | 15-12-2021 | GSK | GlaxoSmithKline PLC | GSK/Sanofi COVID-19 vaccine booster & Ph3 update |
| 11:25 | 13-12-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:35 | 09-12-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 07-12-2021 | GSK | GlaxoSmithKline PLC | Medicago/GSK COVID-19 vaccine positive Ph3 data |
| 07:07 | 07-12-2021 | GSK | GlaxoSmithKline PLC | Sotrovimab retains its activity vs Omicron variant |
| 07:02 | 02-12-2021 | GSK | GlaxoSmithKline PLC | Sotrovimab retains its activity vs Omicron variant |
| 11:05 | 01-12-2021 | GSK | GLAXOSMITHKLINE PLC | Total Voting Rights |
| 16:17 | 24-11-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:00 | 24-11-2021 | GSK | GlaxoSmithKline PLC | GSK publishes provisional 2022 dividend dates |
| 15:06 | 23-11-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 17-11-2021 | GSK | GlaxoSmithKline PLC | Nucala approved in Europe for more indications |
| 16:37 | 15-11-2021 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 12:00 | 12-11-2021 | GSK | GlaxoSmithKline PLC | Phase III IM administration data for sotrovimab |
| 09:23 | 12-11-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:28 | 10-11-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:33 | 05-11-2021 | GSK | GlaxoSmithKline PLC | GSK shares positive Phase III data for daprodustat |
| 17:11 | 01-11-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 14:23 | 27-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 27-10-2021 | GSK | GlaxoSmithKline PLC | 3rd Quarter Results |
| 09:00 | 27-10-2021 | GSK | GlaxoSmithKline PLC | Directorate Change |
| 14:41 | 15-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:28 | 14-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:31 | 14-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:55 | 13-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:17 | 12-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:36 | 12-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:33 | 12-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:30 | 12-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:28 | 12-10-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:54 | 01-10-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:28 | 24-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:58 | 22-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:42 | 20-09-2021 | GSK | GlaxoSmithKline PLC | Director Declaration |
| 17:26 | 13-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:42 | 09-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:54 | 07-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:32 | 03-09-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:44 | 01-09-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 31-08-2021 | GSK | GlaxoSmithKline PLC | SK bio & GSK start Ph3 Covid-19 vaccine trial |
| 14:01 | 25-08-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:39 | 23-08-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:38 | 13-08-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding - amendment |
| 14:18 | 11-08-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:34 | 11-08-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 05-08-2021 | GSK | GlaxoSmithKline PLC | Block Listing Application |
| 14:23 | 02-08-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:32 | 28-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 28-07-2021 | GSK | GlaxoSmithKline PLC | 2nd Quarter Results |
| 16:59 | 26-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:32 | 23-07-2021 | GSK | GlaxoSmithKline PLC | Board Committee Changes |
| 14:45 | 22-07-2021 | GSK | GlaxoSmithKline PLC | CEO Designate of new Consumer Healthcare company |
| 12:00 | 16-07-2021 | GSK | GlaxoSmithKline PLC | GSK announces daprodustat phase 3 headline results |
| 10:24 | 16-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:21 | 15-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:34 | 14-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:17 | 14-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:44 | 13-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:33 | 13-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:23 | 12-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:18 | 12-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:30 | 09-07-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:36 | 02-07-2021 | GSK | GlaxoSmithKline PLC | GSK and Alector collaboration in immuno-neurology |
| 10:41 | 02-07-2021 | GSK | GlaxoSmithKline PLC | Elliott Advisors (UK) letter to GSK |
| 14:29 | 01-07-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:54 | 25-06-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:07 | 24-06-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:00 | 23-06-2021 | GSK | GlaxoSmithKline PLC | GSK to deliver step-change in growth & performance |
| 07:00 | 22-06-2021 | GSK | GlaxoSmithKline PLC | ViiV/Halozyme sign exclusive licensing agreement |
| 11:58 | 14-06-2021 | GSK | GlaxoSmithKline PLC | GSK and iTeos announce collaboration for EOS-448 |
| 16:54 | 11-06-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:28 | 09-06-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:02 | 04-06-2021 | GSK | GlaxoSmithKline PLC | GSK recommend ADR holders reject mini-tender offer |
| 11:33 | 01-06-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 09:21 | 27-05-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 27-05-2021 | GSK | GlaxoSmithKline PLC | Sanofi and GSK initiate new Phase 3 clinical study |
| 07:00 | 27-05-2021 | GSK | GlaxoSmithKline PLC | GSK/Vir Sotrovimab FDA Emergency Use Authorization |
| 10:10 | 24-05-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:58 | 21-05-2021 | GSK | GlaxoSmithKline PLC | GSK/VIR sotrovimab receives positive EMA opinion |
| 13:52 | 18-05-2021 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 07:00 | 18-05-2021 | GSK | GlaxoSmithKline PLC | Medicago/GSK COVID-19 Vaccine Positive Ph2 Results |
| 07:00 | 17-05-2021 | GSK | GlaxoSmithKline PLC | Sanofi/GSK COVID-19 Vaccine Positive Ph2 Results |
| 16:46 | 13-05-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:54 | 11-05-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:30 | 11-05-2021 | GSK | GlaxoSmithKline PLC | EMTN Prospectus |
| 17:50 | 06-05-2021 | GSK | GlaxoSmithKline PLC | Board and Committee Changes |
| 18:23 | 05-05-2021 | GSK | GlaxoSmithKline PLC | Result of AGM |
| 16:29 | 04-05-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:33 | 28-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 28-04-2021 | GSK | GlaxoSmithKline PLC | 1st Quarter Results |
| 16:14 | 26-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:00 | 23-04-2021 | GSK | GlaxoSmithKline PLC | EU approves GSKs JEMPERLI (dostarlimab-gxly) |
| 07:00 | 23-04-2021 | GSK | GlaxoSmithKline PLC | FDA approves GSKs JEMPERLI (dostarlimab-gxly) |
| 16:00 | 16-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:21 | 15-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:17 | 15-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:14 | 14-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:58 | 14-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:32 | 12-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:48 | 12-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:34 | 09-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:35 | 09-04-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:30 | 06-04-2021 | GSK | GlaxoSmithKline PLC | Directorate Change |
| 15:36 | 01-04-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:21 | 30-03-2021 | GSK | GlaxoSmithKline PLC | Publication of 2021 AGM Notice |
| 11:30 | 30-03-2021 | GSK | GlaxoSmithKline PLC | GSK respiratory product sales reporting changes |
| 12:30 | 24-03-2021 | GSK | GlaxoSmithKline PLC | Moncef Slaoui Departs Galvani Bioelectronics |
| 16:31 | 23-03-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 18:24 | 17-03-2021 | GSK | GlaxoSmithKline PLC | Chair of Audit & Risk Committee |
| 11:08 | 16-03-2021 | GSK | GlaxoSmithKline PLC | Medicago and GSK start Phase 3 trial |
| 17:27 | 15-03-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 15-03-2021 | GSK | GlaxoSmithKline PLC | Annual Report 2020 on Form 20-F |
| 14:25 | 11-03-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 11-03-2021 | GSK | GlaxoSmithKline PLC | GSK and Vir share positive VIR-7831 data in COVID |
| 13:23 | 10-03-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:43 | 09-03-2021 | GSK | GlaxoSmithKline PLC | Annual Financial Report |
| 15:48 | 02-03-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:55 | 01-03-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 12:00 | 25-02-2021 | GSK | GlaxoSmithKline PLC | GSK announces otilimab data for treatment of COVID |
| 13:59 | 24-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:13 | 24-02-2021 | GSK | GlaxoSmithKline PLC | Holding(s) in Company |
| 09:03 | 23-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:39 | 22-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:40 | 22-02-2021 | GSK | GlaxoSmithKline PLC | Sanofi and GSK initiate new Phase 2 study |
| 12:52 | 19-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:31 | 19-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:32 | 19-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:59 | 18-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 17-02-2021 | GSK | GlaxoSmithKline PLC | GSK/Vir collaborate on antibodies for influenza |
| 09:00 | 17-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:09 | 15-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:15 | 15-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:26 | 12-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:23 | 12-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:20 | 12-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:05 | 10-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:54 | 10-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:15 | 04-02-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 03-02-2021 | GSK | GlaxoSmithKline PLC | Final Results |
| 07:00 | 03-02-2021 | GSK | GlaxoSmithKline PLC | GSK/CureVac partner on new mRNA Covid-19 vaccines |
| 14:04 | 01-02-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:26 | 26-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 22-01-2021 | GSK | GlaxoSmithKline PLC | FDA approves ViiV Healthcares Cabenuva for HIV |
| 16:00 | 20-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:50 | 20-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:02 | 20-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 18:02 | 19-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:31 | 18-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:00 | 15-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:14 | 15-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:45 | 13-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:05 | 11-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:16 | 11-01-2021 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:25 | 04-01-2021 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 11:52 | 30-12-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:44 | 23-12-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 21-12-2020 | GSK | GlaxoSmithKline PLC | ViiV first long-acting HIV regimen approved in EU |
| 07:00 | 11-12-2020 | GSK | GlaxoSmithKline PLC | Sanofi/ GSK update on COVID vaccine candidate |
| 17:51 | 10-12-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:55 | 10-12-2020 | GSK | GlaxoSmithKline PLC | Block Listing Application |
| 15:04 | 09-12-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:53 | 03-12-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:00 | 01-12-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 14:58 | 27-11-2020 | GSK | GlaxoSmithKline PLC | GSK publishes provisional 2021 dividend dates |
| 12:35 | 26-11-2020 | GSK | GlaxoSmithKline PLC | EMTN Supplementary Prospectus |
| 10:26 | 25-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 08:59 | 23-11-2020 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 17:40 | 19-11-2020 | GSK | GlaxoSmithKline PLC | Holding(s) in Company |
| 17:48 | 17-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:00 | 12-11-2020 | GSK | GlaxoSmithKline PLC | Medicago GSK phase 2/3 study start |
| 15:08 | 11-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:13 | 11-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 09-11-2020 | GSK | GlaxoSmithKline PLC | ViiVs cabotegravir superior for HIV prevention |
| 17:32 | 04-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:45 | 04-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:09 | 03-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 08:00 | 03-11-2020 | GSK | GlaxoSmithKline PLC | GSK sets new environmental goals |
| 17:16 | 02-11-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:59 | 02-11-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:08 | 30-10-2020 | GSK | GlaxoSmithKline PLC | Holding(s) in Company |
| 12:53 | 30-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:46 | 28-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 28-10-2020 | GSK | GlaxoSmithKline PLC | 3rd Quarter Results |
| 07:00 | 28-10-2020 | GSK | GlaxoSmithKline PLC | Sanofi and GSK support COVAX - 200m vaccine doses |
| 12:34 | 22-10-2020 | GSK | GlaxoSmithKline PLC | Holding(s) in Company |
| 12:18 | 16-10-2020 | GSK | GlaxoSmithKline PLC | Positive CHMP opinion ViiV long-acting HIV regimen |
| 15:30 | 14-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:29 | 14-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:41 | 13-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:08 | 13-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:01 | 13-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:55 | 13-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:49 | 13-10-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:30 | 01-10-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:42 | 22-09-2020 | GSK | GlaxoSmithKline PLC | Sanofi/GSK agree up to 72m Canada COVID doses |
| 15:17 | 11-09-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:01 | 10-09-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:11 | 09-09-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:47 | 09-09-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 03-09-2020 | GSK | GlaxoSmithKline PLC | Sanofi/GSK: Phase 1/2 trial of COVID-19 vaccine |
| 15:23 | 01-09-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 10:48 | 13-08-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 06-08-2020 | GSK | GlaxoSmithKline PLC | US FDA approves GSK's BLENREP for multiple myeloma |
| 11:31 | 03-08-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 03-08-2020 | GSK | GlaxoSmithKline PLC | Sanofi/GSK to supply EU with 300m COVID 19 doses |
| 12:00 | 31-07-2020 | GSK | GlaxoSmithKline PLC | Sanofi & GSK picked for Op. Warp Speed by US Gov. |
| 14:02 | 29-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 29-07-2020 | GSK | GlaxoSmithKline PLC | 2nd Quarter Results |
| 07:00 | 29-07-2020 | GSK | GlaxoSmithKline PLC | Sanofi and GSK agree UK doses of COVID-19 vaccine |
| 15:23 | 28-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:16 | 24-07-2020 | GSK | GlaxoSmithKline PLC | GSK receives positive CHMP opinion for Belamaf |
| 07:00 | 20-07-2020 | GSK | GlaxoSmithKline PLC | GSK and CureVac enter collaboration |
| 09:31 | 15-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 15-07-2020 | GSK | GlaxoSmithKline PLC | FDA Panel Votes IN FAVOR of Belantamab mafodotin |
| 13:19 | 14-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:42 | 13-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:41 | 10-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:15 | 10-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:07 | 10-07-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:25 | 01-07-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 08:00 | 29-06-2020 | GSK | GlaxoSmithKline PLC | GSK's daprodustat gains first regulatory approval |
| 15:22 | 19-06-2020 | GSK | GlaxoSmithKline PLC | FDA Advisory Committee review belantamab mafodotin |
| 12:25 | 18-06-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:51 | 16-06-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:56 | 11-06-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:16 | 09-06-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:14 | 01-06-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:41 | 29-05-2020 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 16:37 | 29-05-2020 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 11:53 | 26-05-2020 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 07:09 | 18-05-2020 | GSK | GlaxoSmithKline PLC | ViiV PrEP jab shows high efficacy over daily pill |
| 17:04 | 13-05-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:52 | 07-05-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:56 | 07-05-2020 | GSK | GlaxoSmithKline PLC | GSK sells its holding in Hindustan Unilever |
| 17:40 | 06-05-2020 | GSK | GlaxoSmithKline PLC | Result of AGM |
| 17:40 | 04-05-2020 | GSK | GlaxoSmithKline PLC | Publication of a Prospectus |
| 16:18 | 04-05-2020 | GSK | GlaxoSmithKline PLC | Rights attached to ordinary shares |
| 15:45 | 01-05-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 30-04-2020 | GSK | GlaxoSmithKline PLC | GSK's Zejula approved in first-line ovarian cancer |
| 12:00 | 29-04-2020 | GSK | GlaxoSmithKline PLC | 1st Quarter Results |
| 11:00 | 29-04-2020 | GSK | GlaxoSmithKline PLC | Arrangements for Shareholder Webcast |
| 15:25 | 16-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:21 | 16-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:49 | 16-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:35 | 14-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:31 | 14-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:09 | 14-04-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 14-04-2020 | GSK | GlaxoSmithKline PLC | Sanofi and GSK collaboration to fight COVID-19 |
| 11:52 | 09-04-2020 | GSK | GlaxoSmithKline PLC | AGM - Change of Arrangements |
| 13:00 | 06-04-2020 | GSK | GlaxoSmithKline PLC | GSK and Vir Biotechnology enter collaboration |
| 12:57 | 01-04-2020 | GSK | GlaxoSmithKline PLC | GSK completes divestment of Horlicks |
| 11:11 | 01-04-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:06 | 30-03-2020 | GSK | GlaxoSmithKline PLC | Consumer Healthcare product sales category changes |
| 16:42 | 25-03-2020 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 16:37 | 25-03-2020 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 16:40 | 24-03-2020 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 16:35 | 24-03-2020 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 07:00 | 24-03-2020 | GSK | GlaxoSmithKline PLC | Publication of AGM Notice |
| 14:00 | 20-03-2020 | GSK | GlaxoSmithKline PLC | Directorate Change |
| 12:20 | 18-03-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:24 | 13-03-2020 | GSK | GlaxoSmithKline PLC | EMTN Prospectus Supplement Update |
| 17:00 | 11-03-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:15 | 09-03-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 09-03-2020 | GSK | GlaxoSmithKline PLC | Publication of GSK 2019 Form 20-F |
| 14:53 | 04-03-2020 | GSK | GlaxoSmithKline PLC | Annual Financial Report |
| 11:00 | 02-03-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:00 | 21-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:30 | 20-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 20-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 20-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:35 | 19-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:28 | 19-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:24 | 19-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:17 | 19-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:05 | 12-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:15 | 11-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 11-02-2020 | GSK | GlaxoSmithKline PLC | Transfer of Treasury Shares |
| 16:00 | 06-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:15 | 05-02-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 05-02-2020 | GSK | GlaxoSmithKline PLC | Final Results |
| 15:15 | 03-02-2020 | GSK | GlaxoSmithKline PLC | GSK publishes provisional 2020 Dividend Dates |
| 09:30 | 03-02-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 15-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:46 | 14-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:01 | 14-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:41 | 13-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:01 | 13-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:34 | 13-01-2020 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:30 | 08-01-2020 | GSK | GlaxoSmithKline PLC | GSK publishes provisional 2020 Dividend Dates |
| 15:11 | 08-01-2020 | GSK | GlaxoSmithKline PLC | GSK publishes 2020 Dividend Dates |
| 14:37 | 08-01-2020 | GSK | GlaxoSmithKline PLC | GSK Announces addition to Corporate Executive Team |
| 09:58 | 02-01-2020 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:01 | 23-12-2019 | GSK | GlaxoSmithKline PLC | ViiV Healthcare receives complete response letter |
| 17:12 | 18-12-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:55 | 18-12-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 17-12-2019 | GSK | GlaxoSmithKline PLC | Blocklisting Application |
| 16:48 | 13-12-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:57 | 11-12-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 05-12-2019 | GSK | GlaxoSmithKline PLC | ViiV submits NDA to FDA for fostemsavir |
| 17:34 | 04-12-2019 | GSK | GlaxoSmithKline PLC | Emma Walmsley - External Appointment |
| 17:52 | 02-12-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:54 | 02-12-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 15:00 | 26-11-2019 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 15:51 | 12-11-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:22 | 08-11-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:36 | 06-11-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:35 | 04-11-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:19 | 01-11-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:53 | 01-11-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:34 | 31-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:32 | 30-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:07 | 30-10-2019 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 12:02 | 30-10-2019 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 08:00 | 21-10-2019 | GSK | GlaxoSmithKline PLC | GSK divests two travel vaccines to Bavarian Nordic |
| 17:00 | 15-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:00 | 15-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:00 | 15-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:00 | 15-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:34 | 11-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:10 | 11-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:18 | 10-10-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:09 | 01-10-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 30-09-2019 | GSK | GlaxoSmithKline PLC | PRIMA shows Zejula improves PFS in ovarian cancer |
| 07:00 | 30-09-2019 | GSK | GlaxoSmithKline PLC | Data show anti-tumour activity with ICOS agonist |
| 17:46 | 17-09-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:30 | 11-09-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:37 | 04-09-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:36 | 04-09-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:33 | 04-09-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:29 | 02-09-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 23-08-2019 | GSK | GlaxoSmithKline PLC | GSK - positive results from pivotal DREAMM-2 study |
| 07:00 | 22-08-2019 | GSK | GlaxoSmithKline PLC | ViiV results positive for every 2 month injection |
| 08:00 | 21-08-2019 | GSK | GlaxoSmithKline PLC | GSK submits regulatory file in Japan: Daprodustat |
| 15:45 | 12-08-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:30 | 01-08-2019 | GSK | GlaxoSmithKline PLC | EU approval for Nucala self-administration |
| 14:10 | 01-08-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 01-08-2019 | GSK | GlaxoSmithKline PLC | GSK completes transaction with Pfizer for New JV |
| 15:35 | 30-07-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 29-07-2019 | GSK | GlaxoSmithKline PLC | ViiV submits cabotegravir to EMA for HIV injection |
| 16:01 | 24-07-2019 | GSK | GlaxoSmithKline PLC | ViiV 2DR TANGO switch study positive at 48 weeks |
| 16:00 | 24-07-2019 | GSK | GlaxoSmithKline PLC | ViiV GEMINI studies show high efficacy at 96 weeks |
| 12:07 | 24-07-2019 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 12:02 | 24-07-2019 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 12:00 | 24-07-2019 | GSK | GlaxoSmithKline PLC | 2nd Quarter Results |
| 10:00 | 24-07-2019 | GSK | GlaxoSmithKline PLC | Non-Executive Chairman |
| 17:00 | 22-07-2019 | GSK | GlaxoSmithKline PLC | ViiV presents 96-week data from phase III study |
| 11:42 | 15-07-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 15-07-2019 | GSK | GlaxoSmithKline PLC | positive results in Phase 3 PRIMA study of ZEJULA |
| 16:35 | 12-07-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:55 | 12-07-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:48 | 10-07-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 10-07-2019 | GSK | GlaxoSmithKline PLC | ViiV switch study shows 2DR as effective as 3DR |
| 09:00 | 03-07-2019 | GSK | GlaxoSmithKline PLC | ViiV receives Dovato EU Marketing Authorisation |
| 12:08 | 01-07-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:10 | 12-06-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 07-06-2019 | GSK | GlaxoSmithKline PLC | FDA approval for Nucala self-administration |
| 08:00 | 04-06-2019 | GSK | GlaxoSmithKline PLC | CHMP positive on GSK's Nucala self-administration |
| 14:31 | 03-06-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 10:54 | 24-05-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:44 | 20-05-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:44 | 13-05-2019 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 16:19 | 13-05-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:07 | 02-05-2019 | GSK | GlaxoSmithKline PLC | Trelegy Ellipta asthma study met primary endpoint |
| 15:11 | 01-05-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:32 | 01-05-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 12:00 | 01-05-2019 | GSK | GlaxoSmithKline PLC | 1st Quarter Results |
| 12:00 | 29-04-2019 | GSK | GlaxoSmithKline PLC | ViiV submits NDA for HIV monthly 2 drug injectable |
| 17:36 | 16-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:35 | 16-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:23 | 16-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:14 | 16-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:45 | 15-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:33 | 12-04-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 09-04-2019 | GSK | GlaxoSmithKline PLC | FDA approves ViiV's two-drug HIV regimen, Dovato |
| 13:00 | 02-04-2019 | GSK | GlaxoSmithKline PLC | Publication of AGM and GM Shareholder Documents |
| 16:15 | 28-03-2019 | GSK | GlaxoSmithKline PLC | GSK reporting changes - product sales and IFRS 16 |
| 17:02 | 25-03-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:45 | 19-03-2019 | GSK | GlaxoSmithKline PLC | Data from GARNET study evaluating dostarlimab |
| 07:00 | 18-03-2019 | GSK | GlaxoSmithKline PLC | GSK Annual Report 2018 on Form 20-F |
| 15:19 | 12-03-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:00 | 12-03-2019 | GSK | GlaxoSmithKline PLC | Annual Financial Report |
| 18:24 | 11-03-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 08-03-2019 | GSK | GlaxoSmithKline PLC | ViiV positive ph3 data for long acting injectable |
| 10:10 | 01-03-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:30 | 22-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:21 | 22-02-2019 | GSK | GlaxoSmithKline PLC | GSK response to SFO Statement |
| 16:37 | 21-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:15 | 21-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:44 | 20-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:26 | 19-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:53 | 19-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding Replacement |
| 13:41 | 19-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:13 | 18-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:14 | 18-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:39 | 15-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:33 | 14-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:05 | 12-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:03 | 12-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:42 | 11-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:40 | 11-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:38 | 11-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:02 | 11-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:01 | 11-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:16 | 08-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:17 | 08-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:20 | 06-02-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:01 | 06-02-2019 | GSK | GlaxoSmithKline PLC | Final Results |
| 11:58 | 05-02-2019 | GSK | GlaxoSmithKline PLC | GSK and Merck announce global alliance for M7824 |
| 15:45 | 01-02-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:10 | 23-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:56 | 22-01-2019 | GSK | GlaxoSmithKline PLC | GSK completes acquisition of TESARO |
| 07:00 | 21-01-2019 | GSK | GlaxoSmithKline PLC | GSK Chairman succession process |
| 17:15 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:09 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:01 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:59 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:56 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:47 | 15-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:00 | 15-01-2019 | GSK | GlaxoSmithKline PLC | GlaxoSmithKline Extends Tender Offer for TESARO |
| 16:32 | 11-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:25 | 11-01-2019 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:45 | 02-01-2019 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:15 | 20-12-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 19-12-2018 | GSK | GlaxoSmithKline PLC | GSK and Pfizer create new Consumer Healthcare JV |
| 13:20 | 14-12-2018 | GSK | GlaxoSmithKline PLC | GSK Commences Tender Offer for TESARO Inc. |
| 16:35 | 12-12-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:07 | 04-12-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 03-12-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 12:02 | 03-12-2018 | GSK | GlaxoSmithKline PLC | GSK reaches agreement to acquire TESARO |
| 08:35 | 03-12-2018 | GSK | GlaxoSmithKline PLC | GSK to divest Horlicks to Unilever |
| 16:40 | 30-11-2018 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 16:35 | 30-11-2018 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 15:40 | 29-11-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:45 | 29-11-2018 | GSK | GlaxoSmithKline PLC | GSK - Update on Review of Horlicks |
| 15:25 | 27-11-2018 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 13:02 | 22-11-2018 | GSK | GlaxoSmithKline PLC | GSK publishes 2019 Dividend Dates |
| 14:45 | 12-11-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 12-11-2018 | GSK | GlaxoSmithKline PLC | Blocklisting Application |
| 12:43 | 08-11-2018 | GSK | GlaxoSmithKline PLC | Director Declaration |
| 16:15 | 02-11-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:40 | 01-11-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 14:15 | 31-10-2018 | GSK | GlaxoSmithKline PLC | ViiV positive phIII results with fostemsavir |
| 12:07 | 31-10-2018 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 12:02 | 31-10-2018 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 12:00 | 31-10-2018 | GSK | GlaxoSmithKline PLC | 3rd Quarter Results |
| 14:30 | 30-10-2018 | GSK | GlaxoSmithKline PLC | ViiV: positive data for long-acting injectable |
| 10:00 | 29-10-2018 | GSK | GlaxoSmithKline PLC | ViiV - three-year data for long-acting injectable |
| 16:00 | 18-10-2018 | GSK | GlaxoSmithKline PLC | ViiV submits HIV 2DR regulatory application to FDA |
| 09:34 | 18-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:56 | 17-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:50 | 17-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:30 | 17-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:53 | 16-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:30 | 16-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:30 | 16-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:30 | 10-10-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:58 | 01-10-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 16:35 | 27-09-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:30 | 21-09-2018 | GSK | GlaxoSmithKline PLC | CHMP recommends expansion of Trelegy COPD label |
| 09:00 | 14-09-2018 | GSK | GlaxoSmithKline PLC | ViiV submits HIV 2DR regulatory application to EMA |
| 17:43 | 12-09-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 08:00 | 10-09-2018 | GSK | GlaxoSmithKline PLC | New analysis on efficacy of anti-IL5 biologics SEA |
| 07:00 | 10-09-2018 | GSK | GlaxoSmithKline PLC | GSK receives CRL from FDA for mepolizumab in COPD |
| 14:24 | 07-09-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:18 | 07-09-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:00 | 03-09-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:12 | 30-08-2018 | GSK | GlaxoSmithKline PLC | GSK publishes Q4 2018 Dividend Dates |
| 08:12 | 30-08-2018 | GSK | GlaxoSmithKline PLC | EU approve Nucala in severe asthma in children |
| 10:16 | 24-08-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 15-08-2018 | GSK | GlaxoSmithKline PLC | Positive headline results for ViiV HC ATLAS study |
| 15:00 | 10-08-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:35 | 08-08-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 07:00 | 07-08-2018 | GSK | GlaxoSmithKline PLC | Iain Mackay appointed GSK Chief Financial Officer |
| 11:04 | 02-08-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 17:03 | 31-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:37 | 31-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:30 | 27-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:47 | 27-07-2018 | GSK | GlaxoSmithKline PLC | CHMP recommend Nucala for severe asthma children |
| 07:00 | 26-07-2018 | GSK | GlaxoSmithKline PLC | GSK reports on FDA Ad Com on mepolizumab for COPD |
| 16:15 | 25-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:00 | 25-07-2018 | GSK | GlaxoSmithKline PLC | 2nd Quarter Results |
| 11:00 | 25-07-2018 | GSK | GlaxoSmithKline PLC | GSK and 23andMe Agreement |
| 09:01 | 24-07-2018 | GSK | GlaxoSmithKline PLC | ViiV announces Juluca 100 week data at AIDS 2018 |
| 09:00 | 24-07-2018 | GSK | GlaxoSmithKline PLC | ViiV shows positive phIII data on two-drug combo |
| 16:45 | 19-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:46 | 17-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:54 | 17-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:49 | 17-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:51 | 16-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:11 | 16-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:16 | 13-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:16 | 13-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:42 | 11-07-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:30 | 02-07-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 14-06-2018 | GSK | GlaxoSmithKline PLC | Positive headline results for ViiV GEMINI studies |
| 17:15 | 12-06-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:00 | 12-06-2018 | GSK | GlaxoSmithKline PLC | GSK announces changes to Corporate Executive Team |
| 13:00 | 01-06-2018 | GSK | GlaxoSmithKline PLC | GSK completes Consumer Healthcare buyout |
| 09:42 | 01-06-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 07:00 | 29-05-2018 | GSK | GlaxoSmithKline PLC | GSK Once-daily single inhaler triple therapy COPD |
| 11:02 | 21-05-2018 | GSK | GlaxoSmithKline PLC | ViiV granted EU marketing authorisation for Juluca |
| 14:00 | 02-01-2018 | GSK | GlaxoSmithKline PLC | Director Shareholding |
| 13:54 | 02-01-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 15:33 | 11-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:04 | 15-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:18 | 15-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:59 | 15-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:54 | 15-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:34 | 15-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:48 | 16-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:19 | 19-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:17 | 19-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:22 | 23-01-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 26-01-2018 | GSK | GlaxoSmithKline PLC | GSK's Relvar Ellipta - positive CHMP opinion |
| 12:30 | 26-01-2018 | GSK | GlaxoSmithKline PLC | GSK's Shingrix - positive CHMP opinion in Europe |
| 11:52 | 01-02-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:19 | 07-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:01 | 07-02-2018 | GSK | GlaxoSmithKline PLC | Final Results |
| 09:04 | 07-02-2018 | GSK | GlaxoSmithKline PLC | GSK's Bexsero FDA Breakthrough Therapy Designation |
| 07:00 | 08-02-2018 | GSK | GlaxoSmithKline PLC | ViiV files patent infringement litigation |
| 09:31 | 08-02-2018 | GSK | GlaxoSmithKline PLC | ViiV Healthcare launches new two-drug HIV study |
| 12:47 | 12-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:43 | 12-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:44 | 13-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 09:00 | 14-02-2018 | GSK | GlaxoSmithKline PLC | GSK submits landmark IMPACT data - Trelegy Ellipta |
| 17:53 | 15-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 18:09 | 15-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:57 | 15-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:20 | 16-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:25 | 16-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:29 | 16-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 18:12 | 19-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:16 | 20-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:17 | 20-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:15 | 20-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 16:54 | 22-02-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:16 | 01-03-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 13:11 | 02-03-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:47 | 05-03-2018 | GSK | GlaxoSmithKline PLC | Nucala OSMO study presented at AAAAI-WAO congress |
| 12:04 | 05-03-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:01 | 05-03-2018 | GSK | GlaxoSmithKline PLC | ViiV Healthcare announces new dolutegravir data |
| 08:00 | 08-03-2018 | GSK | GlaxoSmithKline PLC | GSK announces labelling update to Relvar Ellipta |
| 16:30 | 12-03-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:10 | 13-03-2018 | GSK | GlaxoSmithKline PLC | Annual Financial Report |
| 07:00 | 19-03-2018 | GSK | GlaxoSmithKline PLC | GSK 2017 Form 20-F |
| 07:44 | 23-03-2018 | GSK | GlaxoSmithKline PLC | Update regarding Pfizer Inc. Consumer Healthcare |
| 11:21 | 23-03-2018 | GSK | GlaxoSmithKline PLC | ViiV - CHMP positive opinion for Juluca in Europe |
| 07:00 | 23-03-2018 | GSK | GlaxoSmithKline PLC | Shingrix approved in Europe and Japan |
| 07:00 | 27-03-2018 | GSK | GlaxoSmithKline PLC | GSK agrees to acquire CH business from Novartis |
| 13:00 | 29-03-2018 | GSK | GlaxoSmithKline PLC | Notice of AGM |
| 16:14 | 03-04-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 15:04 | 12-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:44 | 13-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 11:32 | 13-04-2018 | GSK | GlaxoSmithKline PLC | Notice of GM |
| 15:50 | 13-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:20 | 17-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:30 | 17-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:36 | 17-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:24 | 17-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:47 | 17-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 10:34 | 18-04-2018 | GSK | GlaxoSmithKline PLC | Landmark IMPACT study to be published in NEJM |
| 07:00 | 19-04-2018 | GSK | GlaxoSmithKline PLC | IMPACT study shows benefits of Trelegy Ellipta |
| 15:15 | 20-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 15:15 | 20-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 17:41 | 24-04-2018 | GSK | GlaxoSmithKline PLC | Trelegy Ellipta expanded US COPD indication |
| 12:07 | 25-04-2018 | GSK | GlaxoSmithKline PLC | Second Price Monitoring Extn |
| 12:00 | 25-04-2018 | GSK | GlaxoSmithKline PLC | 1st Quarter Results |
| 12:02 | 25-04-2018 | GSK | GlaxoSmithKline PLC | Price Monitoring Extension |
| 15:30 | 26-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 12:43 | 27-04-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 14:45 | 01-05-2018 | GSK | GlaxoSmithKline PLC | Total Voting Rights |
| 18:31 | 03-05-2018 | GSK | GlaxoSmithKline PLC | Result of General Meeting |
| 18:29 | 03-05-2018 | GSK | GlaxoSmithKline PLC | Result of AGM |
| 17:05 | 09-05-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding - replacement |
| 12:00 | 09-05-2018 | GSK | GlaxoSmithKline PLC | Directorate Change |
| 17:20 | 10-05-2018 | GSK | GlaxoSmithKline PLC | Block listing Interim Review |
| 15:17 | 11-05-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |
| 13:39 | 15-05-2018 | GSK | GlaxoSmithKline PLC | Director/PDMR Shareholding |